Ulbricht David, Pippel Jan, Schultz Stephan, Meier René, Sträter Norbert, Heiker John T
Institute of Biochemistry, Faculty of Biosciences, Pharmacy and Psychology, University of Leipzig, 04103 Leipzig, Germany.
Center for Biotechnology and Biomedicine, Institute of Bioanalytical Chemistry, University of Leipzig, 04103 Leipzig, Germany.
Biochem J. 2015 Sep 15;470(3):357-67. doi: 10.1042/BJ20150643. Epub 2015 Jul 21.
SerpinA12 (vaspin) is thought to be mainly expressed in adipose tissue and has multiple beneficial effects on metabolic, inflammatory and atherogenic processes related to obesity. KLK7 (kallikrein 7) is the only known protease target of vaspin to date and is inhibited with a moderate inhibition rate. In the crystal structure, the cleavage site (P1-P1') of the vaspin reactive centre loop is fairly rigid compared with the flexible residues before P2, possibly supported by an ionic interaction of P1' glutamate (Glu(379)) with an arginine residue (Arg(302)) of the β-sheet C. A P1' glutamate seems highly unusual and unfavourable for the protease KLK7. We characterized vaspin mutants to investigate the roles of these two residues in protease inhibition and recognition by vaspin. Reactive centre loop mutations changing the P1' residue or altering the reactive centre loop conformation significantly increased inhibition parameters, whereas removal of the positive charge within β-sheet C impeded the serpin-protease interaction. Arg(302) is a crucial contact to enable vaspin recognition by KLK7 and it supports moderate inhibition of the serpin despite the presence of the detrimental P1' Glu(379), which clearly represents a major limiting factor for vaspin-inhibitory activity. We also show that the vaspin-inhibition rate for KLK7 can be modestly increased by heparin and demonstrate that vaspin is a heparin-binding serpin. Noteworthily, we observed vaspin as a remarkably thermostable serpin and found that Glu(379) and Arg(302) influence heat-induced polymerization. These structural and functional results reveal the mechanistic basis of how reactive centre loop sequence and exosite interaction in vaspin enable KLK7 recognition and regulate protease inhibition as well as stability of this adipose tissue-derived serpin.
丝氨酸蛋白酶抑制剂A12(内脏脂肪素)被认为主要在脂肪组织中表达,对与肥胖相关的代谢、炎症和动脉粥样硬化过程具有多种有益作用。激肽释放酶7(KLK7)是迄今为止已知的内脏脂肪素唯一的蛋白酶靶点,其抑制率适中。在晶体结构中,与P2之前的柔性残基相比,内脏脂肪素反应中心环的切割位点(P1-P1')相当刚性,这可能由P1'谷氨酸(Glu(379))与β-折叠C的精氨酸残基(Arg(302))的离子相互作用所支持。P1'谷氨酸似乎非常不寻常,对蛋白酶KLK7不利。我们对内脏脂肪素突变体进行了表征,以研究这两个残基在蛋白酶抑制和内脏脂肪素识别中的作用。改变P1'残基或改变反应中心环构象的反应中心环突变显著增加了抑制参数,而去除β-折叠C内的正电荷则阻碍了丝氨酸蛋白酶抑制剂与蛋白酶的相互作用。Arg(302)是使KLK7能够识别内脏脂肪素的关键接触点,尽管存在有害的P1' Glu(379),它仍支持对丝氨酸蛋白酶抑制剂的适度抑制,这显然是内脏脂肪素抑制活性的主要限制因素。我们还表明,肝素可适度提高内脏脂肪素对KLK7的抑制率,并证明内脏脂肪素是一种肝素结合丝氨酸蛋白酶抑制剂。值得注意的是,我们观察到内脏脂肪素是一种非常耐热的丝氨酸蛋白酶抑制剂,并发现Glu(379)和Arg(302)影响热诱导的聚合反应。这些结构和功能结果揭示了内脏脂肪素中反应中心环序列和外部位点相互作用如何实现KLK7识别并调节蛋白酶抑制以及这种脂肪组织来源的丝氨酸蛋白酶抑制剂稳定性的机制基础。